Functions of RNA N6-methyladenosine modification in cancer progression. 2019

Bing Chen, and Ya Li, and Ruifeng Song, and Chen Xue, and Feng Xu
Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, 1 Jianshe Eastern Road, Zhengzhou, 450052, People's Republic of China.

N6-methyladenosine (m6A) serves as a major RNA methylation modification and impacts the initiation and progression of various human cancers through diverse mechanisms. It has been reported that m6A RNA methylation is involved in different physiological and pathological processes, including stem cell differentiation and motility, immune response, cellular stress, tissue renewal and viral infection. In this review, the m6A modification and its regulatory functions in a few major cancers is introduced. The detection approaches for the m6A sites identification are discussed. Additionally, the potential of the RNA m6A modification in clinical application is discussed.

UI MeSH Term Description Entries
D008745 Methylation Addition of methyl groups. In histo-chemistry methylation is used to esterify carboxyl groups and remove sulfate groups by treating tissue sections with hot methanol in the presence of hydrochloric acid. (From Stedman, 25th ed) Methylations
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012313 RNA A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) RNA, Non-Polyadenylated,Ribonucleic Acid,Gene Products, RNA,Non-Polyadenylated RNA,Acid, Ribonucleic,Non Polyadenylated RNA,RNA Gene Products,RNA, Non Polyadenylated
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease

Related Publications

Bing Chen, and Ya Li, and Ruifeng Song, and Chen Xue, and Feng Xu
May 2021, Biomarker research,
Bing Chen, and Ya Li, and Ruifeng Song, and Chen Xue, and Feng Xu
November 2020, Cell proliferation,
Bing Chen, and Ya Li, and Ruifeng Song, and Chen Xue, and Feng Xu
April 2016, Yi chuan = Hereditas,
Bing Chen, and Ya Li, and Ruifeng Song, and Chen Xue, and Feng Xu
May 2023, Plant communications,
Bing Chen, and Ya Li, and Ruifeng Song, and Chen Xue, and Feng Xu
July 2023, Cell death discovery,
Bing Chen, and Ya Li, and Ruifeng Song, and Chen Xue, and Feng Xu
June 2020, Molecular cancer,
Bing Chen, and Ya Li, and Ruifeng Song, and Chen Xue, and Feng Xu
November 2021, Cancer cell international,
Bing Chen, and Ya Li, and Ruifeng Song, and Chen Xue, and Feng Xu
January 2018, Cell death & disease,
Bing Chen, and Ya Li, and Ruifeng Song, and Chen Xue, and Feng Xu
September 2020, Stem cells (Dayton, Ohio),
Bing Chen, and Ya Li, and Ruifeng Song, and Chen Xue, and Feng Xu
March 2019, Medical oncology (Northwood, London, England),
Copied contents to your clipboard!